Yu Uneno, Akira Yokoyama, Yoshitaka Nishikawa, Taro Funakoshi, Yoshinao Ozaki, Ikuo Aoyama, Kiichiro Baba, Daisuke Yamaguchi, Shuko Morita, Yukiko Mori, Masashi Kanai, Hisanori Kinoshita, Takeshi Inoue, Nobukatsu Sawamoto, Riki Matsumoto, Shigemi Matsumoto, Manabu Muto.

Paraneoplastic limbic encephalitis in human epidermal growth factor receptor-2-positive gastric cancer patient treated with trastuzumab-combined chemotherapy: case report and literature review.

Internal Medicine 55(18):2605-2609, 2016.

Yoshitaka Nishikawa, Hirokazu Higuchi, Osamu Kikuchi, Yasumasa Ezoe, Ikuo Aoyama, Atsushi Yamada, Masataka Kanki, Shuhei Nomura, Motoo Nomura, Takahiro Horimatsu and Manabu Muto.

Factors affecting dilation force in balloon dilation of severe esophageal strictures: an experiment using an artificial stricture model

Surgical Endoscopy 30(10):4315-4320, 2016.

Okuno M, Hatano E, Kasai Y, Nishio T, Seo S, Taura K, Yasuchika K, Nitta T, Mori A, Okajima H, Kaido T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S.

Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases.

Surg Today (2016) 46:721–728

Hironaka S, Sugimoto N, Yamaguchi K, Moriwaki T, Komatsu Y, Nishina T, Tsuji A, Nakajima TE, Gotoh M, Machida N, Bando H, Esaki T, Emi Y, Sekikawa T, Matsumoto S, Takeuchi M, Boku N, Baba H, Hyodo I.

S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial.

The Lancet. Oncology,17,1,99-108

Kondo T, Kitayama H, Sugiyama J, Hirayama M, Suzuki Y, Oyamada Y, Tsuji Y.

Conversion therapy of gastric cancer with massive malignant ascites and ovarian metastases by systemic and intraperitoneal chemotherapy.

Mol Clin Oncol.5:740-744, 2016.

Kitayama H, Kondo T, Sugiyama J, Hirayama M, Oyamada Y, Tsuji Y.

Conversion therapy for pancreatic cancer having peritoneal metastases by intravenous and intraperitoneal paclitaxel with S-1.

Mol Clin Oncol.5:779-782, 2016.

Kitayama H, Kondo T, Sugiyama J, Hirayama M, Oyamada Y, Tsuji Y.

Paraneoplastic erythrocytosis of colon cancer, with serum erythropoietin within the normal reference

Am J Case Rep.17:417-420, 2016.

Kitayama H, Yokota T, Kondo T, Sugiyama J, Hirayama M, Oyamada Y, Tsuji Y.

Unusual Development of Pulmonary Tumor Embolism from Controlled Liver Metastases of Transitional Cell Carcinoma

An Autopsy Case. Intern Med. 55:2453-1456, 2016.

Ishizu S, Setoyama T, Ueo T, Ueda Y, Kodama Y, Ida H, Kawaguchi Y, Yoshizawa A, Chiba T, Miyamoto S.

Concomitant case of intraductal papillary mucinous neoplasm of the pancreas and functioning pancreatic neuroendocrine tumor (Vasoactive intestinal polypeptide-producing tumor) first report.

Pancreas 2016; 45: e24-e25.

Kanai M, Kawaguchi T, Kotaka M, Shinozaki K, Touyama T, Manaka D, Ishigure K, Hasegawa J, Munemoto Y, Matsui T, Takagane A, Ishikawa H, Matsumoto S, Sakamoto J, Saji S, Yoshino T, Ohtsu A, Watanabe T, Matsuda F.

Large-scale prospective pharmacogenomics study of oxaliplatin-induced neuropathy in colon cancer patients enrolled in the JFMC41-1001-C2 (JOIN Trial).

Ann Oncol. 2016 Jun;27(6):1143-8.